Viewing Study NCT00395967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:29 AM
Ignite Modification Date: 2026-01-25 @ 3:39 AM
Study NCT ID: NCT00395967
Status: TERMINATED
Last Update Posted: 2015-05-01
First Post: 2006-11-02
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone
Sponsor: Genzyme, a Sanofi Company
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Lymphoma, Non-Hodgkin's View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Hodgkin's Lymphoma View
None Multiple Myeloma View
None stem cell mobilization View
None autologous transplantation View
None AMD3100 View